Suppr超能文献

合并恶性肿瘤患者诊断深静脉血栓形成的最佳D-二聚体临界值

Optimal D-Dimer Cutoff Values for Diagnosing Deep Vein Thrombosis in Patients with Comorbid Malignancies.

作者信息

Niimi Kiyoaki, Nishida Kazuki, Lee Changi, Ikeda Shuta, Kawai Yohei, Sugimoto Masayuki, Banno Hiroshi

机构信息

Division of Vascular and Endovascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Department of Biostatistics Section, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Ann Vasc Surg. 2024 Jan;98:293-300. doi: 10.1016/j.avsg.2023.06.033. Epub 2023 Jul 15.

Abstract

BACKGROUND

Patients with malignancy are at high risk of venous thromboembolism, and early diagnosis is important. The Khorana score is known as a risk assessment for cancer-related thrombosis during chemotherapy, but there are still few reports on its diagnostic potential, the optimal D-dimer cutoff values for indications other than chemotherapy and the use of the Khorana score in combination with D-dimers. In this study, we examined the clinical appropriateness of increasing the D-dimer cutoff value.

METHODS

We retrospectively studied 208 malignancies out of 556 patients who underwent lower extremity venous ultrasonography at our hospital over a 2-year period from January 2018 to December 2019. The optimal D-dimer cutoff value for predicting deep vein thrombosis (DVT) in patients with malignancy was calculated by the Youden index. The usefulness of the Khorana score alone and the model combining the Khorana score with D-dimer for predicting DVT diagnosis was compared using receiver operating characteristic analysis.

RESULTS

Of 208 eligible patients, 59 (28.4%) had confirmed DVT. The optimal D-dimer cutoff value for predicting DVT comorbidity in patients with malignancy was 3.96 μg/mL. When the new D-dimer cutoff value was set at 4.0 μg/mL, the odds ratio (OR) for DVT diagnosis was 4.23 (95% confidence interval (CI) 2.10-8.55, P < 0.001), which was higher than the OR of 1.33 (95% CI: 0.98-1.81, P = 0.064) for the Khorana score. The area under the curve for the Khorana score and D-dimer was 0.714, which was significantly higher than the 0.611 for the Khorana score alone, with the difference being significantly higher at 0.103 (P = 0.004, 95% CI: 0.033-0.173).

CONCLUSIONS

The optimal D-dimer cutoff value for the diagnosis of DVT in patients with malignancy was 4.0 μg/mL. It was also suggested that the combination of the Khorana score with the D-dimer level was more accurate in diagnosing DVT than the Khorana score alone.

摘要

背景

恶性肿瘤患者发生静脉血栓栓塞的风险很高,早期诊断至关重要。Khorana评分是化疗期间癌症相关血栓形成的风险评估指标,但关于其诊断潜力、化疗以外适应症的最佳D-二聚体临界值以及Khorana评分与D-二聚体联合使用的报道仍然很少。在本研究中,我们探讨了提高D-二聚体临界值的临床适用性。

方法

我们回顾性研究了2018年1月至2019年12月在我院接受下肢静脉超声检查的556例患者中的208例恶性肿瘤患者。通过约登指数计算预测恶性肿瘤患者深静脉血栓形成(DVT)的最佳D-二聚体临界值。使用受试者工作特征分析比较单独的Khorana评分以及Khorana评分与D-二聚体联合模型预测DVT诊断的有效性。

结果

在208例符合条件的患者中,59例(28.4%)确诊为DVT。预测恶性肿瘤患者DVT合并症的最佳D-二聚体临界值为3.96μg/mL。当新的D-二聚体临界值设定为4.0μg/mL时,DVT诊断的比值比(OR)为4.23(95%置信区间(CI)2.10-8.55,P<0.001),高于Khorana评分的OR 1.33(95%CI:0.98-1.81,P=0.064)。Khorana评分和D-二聚体的曲线下面积为0.714,显著高于单独Khorana评分的0.611,差异为0.103,显著更高(P=0.004,95%CI:0.033-0.173)。

结论

恶性肿瘤患者诊断DVT的最佳D-二聚体临界值为4.0μg/mL。还表明,Khorana评分与D-二聚体水平联合在诊断DVT方面比单独的Khorana评分更准确。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验